Navigation Links
Bethesda-Based NHSi Wins $2M Grant for Blood Technology
Date:5/26/2009

BETHESDA, Md., May 26 /PRNewswire/ -- New Health Sciences Inc. (NHSi) has won a two-year award of $1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to develop a groundbreaking blood-storage system.

The project aims to develop the Hemanext Anaerobic Storage Platform, which delivers higher quality blood for transfusion therapy and extends the shelf life of blood for transfusion.

NHSi has demonstrated that this new technology can deliver higher-quality, more physiologic blood, with an improved capacity to deliver oxygen and more deformable red blood cells for better capillary perfusion, and extend by 50 percent or more the shelf life of stored red blood cells.

The Small Business Innovation Research Phase II grant from NIH, announced March 27, follows a 2007-2008 Phase I grant of $133,290.

"This grant is a major step forward for transfusion medicine," NHSi President Martin Cannon said. "Evidence is mounting that, following transfusions, patients experience a multitude of complications resulting in increased morbidity and longer hospital stays that might have been prevented had better stored, better transported, and better preserved blood been used."

"Our technology aims to address this problem and in doing so, reduce the human and economic costs associated with extended hospitalization," Cannon said.

Research has documented that the rate of complications increases with the number of units of blood transfused. Moreover, in a relatively large study, significantly worse post-operative outcomes were associated with blood stored longer than 15 days.

NHSi expects widespread adoption of its Hemanext Anaerobic Storage Platform will reduce the adverse side effects of life-saving blood transfusions and streamline blood-bank operations -- alleviating periodic blood shortages and increasing pre-operative autologous (self-donated) blood donations.

"This research represents a paradigm shift in the approach to storage of red cells, the most significant change since the introduction of additive solutions 25 years ago," Professor James AuBuchon of the University of Washington and President & CEO of Puget Sound Blood Center, said.

"As concern mounts about the clinical impact of storage time of red cell units, reduction in the storage lesion that accumulates has taken on increased importance. Anaerobic storage is a new tool that may not only lengthen but improve the storage of these life-saving cells," AuBuchon said.

NHSi's Director of Research and Development Dr. Tatsuro Yoshida said the new NIH grant "will enable us to move this laboratory technology to everyday use at blood banks by developing an inexpensive, self-contained storage system easily accommodated under current blood-bank operations."

The Medical Device Laboratory, McGowan Institute for Regenerative Medicine at University of Pittsburgh (Professor William Federspiel), Filtertek Inc. of Hebron, Illinois, and Multisorb Technologies of Buffalo, New York, will help develop this new technology.

The clinical trial will be conducted in the laboratory of Dr. Larry J. Dumont at Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire.

In conjunction with this advanced blood storage technology, NHSi is also developing a microchip-based diagnostic device to evaluate the quality of red blood cells stored for transfusion.

Red blood cells' diminished capacity to deform and perfuse narrow capillary networks in tissues is believed to be a major cause of transfusion side effects. Before dispensing a unit of blood to the patient, the NHSi device evaluates the "fitness" of stored red blood cells by passing it through an artificial capillary network produced on a disposable microchip. This work is currently carried out in a partnership with Tulane University.

About New Health Sciences:

NHSi is a privately held company that is developing and commercializing two, strategically linked technologies. The first, Hemodyanamic Vascular Analysis ("HVA"), is a proprietary software and data-based diagnostic and disease management platform. HVA addresses a large and growing need in neurovascular medicine for more precise, inexpensive and safe diagnostic and disease management tools. The second, Hemanext, is novel technology to deliver red blood cells (RBCs) of higher efficacy for transfusion therapy, and at the same time, extend the shelf life of refrigerated RBCs. For more information on the company and other developments, visit www.newhealthsciences.com

    Contact:
    Martin Cannon (301) 493-4586 or Barret Hildebrand (301) 493-4562
    6303 Rockledge Drive, Suite 230
    Bethesda, MD 20817-1818


'/>"/>
SOURCE New Health Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Chinese SFDA Grants Immtech Fast Track Status
6. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
9. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
10. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
11. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
Breaking Medicine News(10 mins):